Data on the hemostasis in epistaxis with Topically Administered TXA Versus Topical Oxymetazoline Spray
The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Data are presented on the efficacy of the topical use of the intravenous formulation of TXA versus the vasoconstrictor oxymetazoline applied topically in achieving hemos...
Main Authors: | Kristen Whitworth, Jacob Johnson, Samuel Wisniewski, Meghan Schrader |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340920301773 |
Similar Items
-
Topical tranexamic acid for spontaneous epistaxis
by: María Jesús Santander, et al.
Published: (2018-12-01) -
Management of benign red eye (evaluation of topical oxymetazoline-a double masked study)
by: Vajpayee R, et al.
Published: (1986-01-01) -
Non‐ST‐elevation myocardial infarction with the use of oxymetazoline nasal spray
by: Saurabh Rajpal, et al.
Published: (2014-01-01) -
Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray
by: Saurabh Rajpal, et al.
Published: (2014-01-01) -
Nasal Bacterial Colonization in Pediatric Epistaxis: The Role of Topical Antibacterial Treatment
by: Mukaddder Korkmaz, et al.
Published: (2016-04-01)